This effect was not due to the inhibition of the KIT-mediated pathway, as this type of IM-resistant GIST cells exhibits an RTK switch (loss of c-KIT/gain of FGFR2a), as described above. This evidence concerns the gene KIT and gastrointestinal stromal tumor.